The burgeoning popularity of retatrutide, initially for blood sugar control , is creating significant interest within the British Isles, prompting a notable shift in hormone trends. Obtaining these treatments remains a complex challenge , with National Health Service provision currently limited and specialist practices offering treatment at a subst